Search the Newsreel

Editas Medicine (EDIT) CFO tax-related share sale executed under preset plan

Editas Medicine's CFO, Amy Parison, sold 678 shares of common stock at $2.58 per share on August 3, 2026. This transaction was executed under a pre-established Rule 10b5-1 plan to cover tax withholding obligations from restricted stock units that vested on August 1, 2026, …

Editas Medicine (Nasdaq: EDIT) equity deal lifts cash to $211.6M

Editas Medicine reported a Q2 2026 net loss of $18.2 million, significantly trimmed from $53.2 million a year prior, and saw collaboration revenues increase to $11.9 million. The company's cash, cash equivalents, and marketable securities totaled $211.6 million as of June 30, 2026, boosted …

Expeditors International stock hits all-time high at 185.48 USD

Expeditors International of Washington Inc. (EXPD) stock reached an all-time high of $185.48, currently trading at $186.01, with a market cap of $23.74 billion, reflecting a 57.66% increase over the past year. Despite being considered overvalued by InvestingPro, analysts like UBS and BofA Securities …

Expeditors of Washington, Inc. Stock 12‑Month Price Target Raised to $165.46, Implies 3% Downside

Expeditors International of Washington, Inc. (EXPD) has seen its average 12-month price target increased by analysts from $159.54 to $165.46, with a range of forecasts between $95 and $207 per share. Based on the August 3rd closing price, this new target suggests a potential …

Expeditors International (NYSE: EXPD) lifts EPS 51% on strong Q2 2026 demand

Expeditors International reported robust Q2 2026 results, with revenues jumping 32% to $3.50 billion and diluted EPS increasing 51% to $2.03, primarily driven by strong demand in airfreight services (up 57%) and customs brokerage (up 27%), largely due to AI infrastructure investments by technology …

Expeditors International of Washington Inc Q2 2026: Revenue $3.502B, EPS $2.03— 10-Q Summary

Expeditors International of Washington Inc. (EXPD) reported strong second-quarter 2026 results, with revenue reaching $3.502 billion and diluted EPS of $2.03. This growth was primarily driven by significant increases in airfreight and customs services compared to the previous year. The company also noted a …

Credit Acceptance Corp. originations steady in Q2

Credit Acceptance Corp.'s originations volume saw a slight increase on a dollar basis in Q2, driven by new dealer sign-ups and technology initiatives. While dollar volume rose by 0.1% year-over-year to $1 billion, unit volume dipped by 1% to 84,615. The subprime lender also …

UBS Adjusts Price Target on Expeditors International of Washington to $210 From $191, Maintains Buy Rating

UBS has increased its price target for Expeditors International of Washington (EXPD) to $210 from $191, while maintaining a Buy rating on the stock. This adjustment comes amidst a series of analyst updates for the company, with several firms modifying their price targets and …

Expeditors Expands Global Aircraft on Ground Services

Expeditors International of Washington, Inc. has expanded its global Aircraft on Ground (AOG) services to address the growing demand for time-critical airfreight logistics. This enhanced offering includes dedicated 24/7/365 support, real-time visibility, flexible transportation, and customs guidance, leveraging Expeditors' worldwide network. The expansion aims …

Barclays Adjusts Price Target on Expeditors International of Washington to $160 From $150

Barclays has adjusted its price target for Expeditors International of Washington (EXPD) to $160, up from the previous target of $150. This change was published on August 5, 2026, at 09:55 am EDT. The article is brief and focuses solely on this analyst price …

Expeditors International of Washington (NASDAQ:EXPD) Hits New 1-Year High Following Strong Earnings

Expeditors International of Washington (NASDAQ:EXPD) reached a new 52-week high after reporting strong Q2 earnings, with EPS of $2.03 significantly beating estimates and revenue up 32.1% year-over-year. The positive results were driven by increased airfreight demand and improved logistics productivity. Despite the strong performance, …

Stephens Adjusts Expeditors International of Washington Price Target to $220 From $200, Maintains Overweight Rating

Stephens has increased its price target for Expeditors International of Washington (EXPD) to $220 from $200, while reiterating an Overweight rating on the stock. This adjustment reflects an updated valuation for the company.

TD Cowen Boosts Expeditors International of Washington (NASDAQ:EXPD) Price Target to $176.00

TD Cowen has raised its price target for Expeditors International of Washington (NASDAQ:EXPD) to $176.00 from $148.00, while maintaining a "sell" rating, implying a potential 3.34% downside. This comes as the company reported strong quarterly earnings of $2.03 EPS, exceeding estimates, and a 32.1% …

JPMorgan Upgrades Expeditors International of Washington to Neutral From Underweight, Adjusts PT to $200 From $144

JPMorgan has upgraded Expeditors International of Washington (EXPD) from Underweight to Neutral and increased its price target from $144 to $200. This change reflects a more optimistic outlook for the company's stock. The article, published on MarketScreener, also mentions other analyst adjustments for EXPD, …

VCREDIT Holdings Limited Provides Group Earnings Guidance for the Six Months Ended June 30, 2026

Credit Corp Group (ASX:CCP) Is Down 6.8% After EPS Rises On Stronger Profit Conversion – Has The Bull Case Changed?

EXPEDITORS INTERNATIONAL OF WASHINGTON INC : TD COWEN RAISES TARGET PRICE TO $176 FROM $148

TD Cowen has increased its target price for Expeditors International of Washington Inc. (EXPD.N) to $176, up from the previous $148. This update reflects an adjusted outlook for the company's stock by the analyst firm. The information was released by Reuters.

Credit Acceptance Corporation Q2 2026 Earnings Call Summary

Editas Medicine (EDIT) Earnings Date and Reports 2026 $EDIT

Editas Medicine earnings beat by $0.12, revenue topped estimates

FS Credit Opportunities to Post Recorded Call Sept. 10

Expeditors International Of Washington (EXPD) Stock Rallies On Profit Strength And Margin Questions

CACC Q2 Earnings Beat as Expenses & Provisions Decline, Revenues Rise

Credit Acceptance Corporation's CACC second-quarter 2026 adjusted earnings per share of $12.12 surpassed the Zacks Consensus Estimate of $11.46. The bottom line increased 20.6% year over year. Shares of CACC lost 2.2% during after-market trading. Results were aided by a marginal rise in revenues …

VCREDIT Warns of Sharp Profit Drop Amid Tighter China Fintech Rules

Price to book forward of OFS Credit Company Inc – GETTEX:1XK

This page from TradingView displays financial information for OFS Credit Company Inc (GETTEX:1XK), specifically focusing on its forward price-to-book ratio. The content indicates that while the market for this stock is currently closed with no trades, detailed financials, news, and community discussions are available. …

ETFs Investing in Expeditors International of Washington, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Expeditors International of Washington, Inc. (EXPD). The list, sorted by market value, provides details such as each fund's weight of EXPD, issuer, management style, expense ratio, assets under management (AUM), and 3-year …

Real Estate Credit Investments Limited Revenue Breakdown – AQUISUK:RECIL

Are Credit Corp Group (ASX:CCP) Shares Undervalued Or Cash Flow Exposed?

Editas Medicine (EDIT) Projected to Post Quarterly Earnings on Tuesday

Editas Medicine (EDIT) is expected to announce its Q2 2026 earnings before market open on Tuesday, August 11th, with analysts forecasting a loss of $0.30 per share and $2.85 million in revenue. The company's previous quarter showed a narrower-than-expected loss but significantly missed revenue …

A cardiovascular leader joins Editas as a director steps down

Editas Medicine has appointed Dr. Patrick T. Ellinor, a renowned leader in cardiovascular medicine and human genetics, to its Board of Directors, effective August 6, 2026. Dr. Ellinor's expertise is expected to significantly contribute to the advancement of EDIT-401 for hyperlipidemia and the company's …

Credit Acceptance Sends 67% of June Calls to AI Agent

Credit Acceptance (CACC) reported strong second-quarter 2026 results with GAAP net income of $135.9 million and adjusted net income of $130.1 million, surpassing the previous year. The company saw its dealer network grow to a record 11,004 active dealers and significantly advanced its AI …

Can Credit Corp Group (ASX:CCP) Balance Value Appeal With Cash Flow Challenges?

Earnings call transcript: Credit Acceptance tops Q2 2026 EPS forecast, shares rise

Credit Acceptance Corporation reported strong Q2 2026 earnings, surpassing EPS forecasts, with GAAP net income up 71% and adjusted net income up 21%. The company's shares rose significantly, driven by lower credit-loss provisions, stronger loan yields, and an improved dealer network, despite a challenging …

Editas Medicine appoints Patrick Ellinor to board of directors

Editas Medicine has appointed Patrick T. Ellinor, M.D., Ph.D., to its Board of Directors, effective August 6. Dr. Ellinor brings extensive experience in human genetics and cardiovascular research from his roles at Mass General Brigham Heart and Vascular Institute and the Broad Institute. He …

Credit Acceptance (NASDAQ:CACC) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS

CREDIT ACCEPTANCE CORP 2Q 2026: Revenue $587.4M, EPS $12.66— 10-Q Summary

CREDIT ACCEPTANCE CORP (CACC) reported strong second-quarter 2026 results, with revenue reaching $587.4M and diluted EPS at $12.66, significantly up from $7.42 a year prior. This growth was primarily driven by lower operating expenses and reduced credit loss provisions. The company also saw record …